For the year ending 2025-12-31, INSP had -$45,337K decrease in cash & cash equivalents over the period. $78,477K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Revenue | 911,981 |
| Cost of goods sold | 133,225 |
| Research and development expense | 103,165 |
| Selling, general and administrative expense (excluding advertising expense) | 509,712 |
| Advertising expense | 114,925 |
| Operating income (loss) | 50,954 |
| Other income | 14,743 |
| Income taxes | -79,725 |
| Net income (loss) | 145,422 |
| Depreciation and amortization | 13,957 |
| Accretion of investment discount | 2,889 |
| Stock-based compensation expense | 130,259 |
| Deferred income taxes (benefit) | -88,749 |
| Provision (benefit) for estimated credit losses | 200 |
| Impairment of strategic investment | 4,046 |
| Other non-cash expenses | 2,111 |
| Accounts receivable | 26,233 |
| Inventories | 65,175 |
| Prepaid expenses and other current assets | -1,651 |
| Accounts payable | -3,747 |
| Accrued expenses and other liabilities | 6,123 |
| Net cash provided by operating activities | 116,976 |
| Purchases of property and equipment | 38,499 |
| Purchases of investments | 240,318 |
| Proceeds from sales or maturities of investments | 310,381 |
| Purchases of strategic investments | 10,118 |
| Net cash provided by (used in) investing activities | 21,446 |
| Proceeds from the exercise of stock options | 9,595 |
| Accelerated share repurchase of common stock | 0 |
| Share repurchase of common stock | 175,019 |
| Payment of taxes on net share settlement of equity awards | 23,044 |
| Proceeds from the issuance of common stock from employee stock purchase plan | 5,019 |
| Net cash (used in) provided by financing activities | -183,449 |
| Effect of exchange rate on cash | -310 |
| Decrease in cash and cash equivalents | -45,337 |
| Cash and cash equivalents at beginning of period | 150,150 |
| Cash and cash equivalents at end of period | 104,813 |
Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems, Inc. (INSP)